Superiority of 68Ga-DOTATATE over 18F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx )-related pheochromocytoma and paraganglioma in the pediatric population

Efficacy of Peptide Receptor Radionuclide Therapy for Functional Metastatic Paraganglioma and Pheochromocytoma

(2017) Grace Kong et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors

(2017) Bruna Babic et al.   SURGERY

Mitochondrial Complex II: At the Crossroads

(2017) Ayenachew Bezawork-Geleta et al.   TRENDS IN BIOCHEMICAL SCIENCES

CHARACTERISTICS AND OUTCOMES OF METASTATIC SDHB AND SPORADIC PHEOCHROMOCYTOMA/PARAGANGLIOMA: AN NATIONAL INSTITUTES OF HEALTH STUDY

(2016) Hana Turkova et al.   Endocrine Practice

PET/CT comparing 68Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma

(2016) Ingo Janssen et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma

(2015) I. Janssen et al.   CLINICAL CANCER RESEARCH

68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI

(2015) I. Janssen et al.   JOURNAL OF NUCLEAR MEDICINE

Usefulness of Somatostatin Receptor Scintigraphy (99mTc-[HYNIC, Tyr3]-Octreotide) and 123I-Metaiodobenzylguanidine Scintigraphy in Patients with SDHx Gene-Related Pheochromocytomas and Paragangliomas Detected by Computed Tomography

(2015) Ilona Michałowska et al.   NEUROENDOCRINOLOGY

Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline

(2014) Jacques W. M. Lenders et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Is there a role for PET-CT and SPECT-CT in pediatric oncology?

(2013) Martin Biermann et al.   ACTA RADIOLOGICA

Staging and Functional Characterization of Pheochromocytoma and Paraganglioma by 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography

(2012) Henri J. L. M. Timmers et al.   JNCI-Journal of the National Cancer Institute

Updated and New Perspectives on Diagnosis, Prognosis, and Therapy of Malignant Pheochromocytoma/Paraganglioma

(2012) Gabriele Parenti et al.   Journal of Oncology

False-positive uptake on 2-[18F]-fluoro-2-deoxy-d-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imaging

(2011) A.D. Culverwell et al.   CLINICAL RADIOLOGY

No Child Left Behind in SDHB Testing for Paragangliomas and Pheochromocytomas

(2011) Joshua D. Schiffman   JOURNAL OF CLINICAL ONCOLOGY

Metastatic Pheochromocytoma/Paraganglioma Related to Primary Tumor Development in Childhood or Adolescence: Significant Link toSDHBMutations

(2011) Kathryn S. King et al.   JOURNAL OF CLINICAL ONCOLOGY

Pheochromocytoma

(2011) S. Edmonds et al.   PEDIATRICS IN REVIEW

SDHA is a tumor suppressor gene causing paraganglioma

(2010) Nelly Burnichon et al.   HUMAN MOLECULAR GENETICS

Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators

(2010) Montserrat Ayala-Ramirez et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma

(2010) Jean-Pierre Bayley et al.   LANCET ONCOLOGY

The Warburg Effect Is Genetically Determined in Inherited Pheochromocytomas

(2009) Judith Favier et al.   PLoS One

Radiation risks from imaging studies in children with cancer

(2008) Elizabeth Robbins   PEDIATRIC BLOOD & CANCER